Atea Pharmaceuticals Earning Date (AVIR)

USA |NASDAQ |USD

AVIR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 10, 2022 Jun 2022 - - $0.02
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 10, 2022 Jun 2022 - - $60.39M

Atea Pharmaceuticals's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 2022.

AVIR Earnings Date & History Chart

AVIR Earnings & Revenue Forecast

AVIR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $-1.74 $-3.03 $-0.48

AVIR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 0 $-0.98 $0.30 $14.30

AVIR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $117.50M $10.00M $225.00M

AVIR Earnings Date & Revenue History

AVIR Earnings History

|
Show More
Show More

AVIR Revenue History

|
Show More
Show More

Atea Pharmaceuticals Next Earnings Date & Report

AVIR Next Earnings Date & Report Preview: Jun 2022 (FQ)

AVIR's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 30, 2022.

Atea Pharmaceuticals Previous Earnings Dates & Reports

AVIR Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Atea Pharmaceuticals's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.

AVIR Previous Earnings Date & Report Recap: Dec 2021 (FY)

Atea Pharmaceuticals's previous annual earnings date was Feb 28, 2022 for its fiscal year ended Dec 31, 2021.

AVIR's earnings per share (EPS) was $1.36, beating the consensus analysts forecast of $0.09 by 1411.11% , and higher than the previous year's EPS (Dec 2020) by 54.55%.

Revenues were $351.37M, better than the forecast of $234.86M by 49.61%, and up by 622.49% from previous year's revenue.

The company reported a net income of $121.19M.

Atea Pharmaceuticals reported a free cash flow of $-87.01M for its fiscal year, compared to $296.71M a year ago.